|
I Kupfermann |
MH35564-28 |
281,707
|
Behavioral and
Neural Analysis of Learning in Aplysia |
|
J Endicott |
MH23864-29 |
155,106
|
NIMH Collaborative
Depression Study |
|
L E-Kimling |
MH19560-30 |
637,598
|
Prospective Study
of Children of Schizophrenic Parents |
|
D Friedman |
HD14959-16 |
276,123
|
The Maturation of
Cognitive-Related Brain Potentials |
|
H Sackeim |
MH35636-20 |
393,994
|
Affective and
Cognitive Consequences of ECT |
|
C Bailey |
MH37134-18 |
278,277
|
Morphological Basis
of Synaptic Plasticity |
|
C Malapani |
MH41649-16 |
166,765
|
Theory of Animal
Timing: Memory and Choice |
|
M Terman |
MH42931-13 |
327,363
|
Light and Ion
Therapy for Seasonal Affective Disorder |
|
A Ehrhardt |
MH43520-14 |
2,630,336
|
HIV Center for
Clinical and Behavioral Studies |
|
D Hasin |
AA08159-08 |
658,999
|
Alcohol Dependence:
General Population Validity |
|
D Friedman |
AG09988-09 |
351,324
|
Age-Related ERP
Measures in Alzheimer's Disease |
|
R Foltin |
DA04130-15 |
175,750
|
Anorectic Drugs:
Abuse & Behavioral Mechanisms of Action |
|
C Hart |
DA03476-17 |
630,271
|
Drug Effects on
Behavior: Workplace Implications |
|
R Foltin |
DA08105-08 |
399,001
|
Laboratory Analysis
of Cocaine Abstinence |
|
G Bruder |
MH50715-08 |
253,181
|
Brain ERPs and
Cognitive Demand in Schizophrenia |
|
V Arango |
MH40210-17 |
403,519
|
Postmortem
Neurochemical Studies in Suicide |
|
W Fifer |
HD32774-07 |
418,885
|
Perinatal
Assessment of At-Risk Populations |
|
H Kleber |
DA09236-08 |
1,959,826
|
Novel Medication
Approaches for Substance Abuse |
|
S Evans |
DA09114-08 |
434,157
|
Vulnerbility to
Anxiolytic Abuse in Women |
|
A Skodol |
MH50839-06 |
321,346
|
Collaborative
Longitudinal Study of Personality Disorders |
|
M Laruelle |
MH54192-07 |
312,700
|
SPECT Imaging of
Dopamine Function in Schizophrenia |
|
M Liebowitz |
MH45436-09 |
333,805
|
CBT Augmentation of
SRI Pharmacotherapy for OCD |
|
P Mcgrath |
MH56058-05 |
251,135
|
Prediction of
Outcome During Fluoxetine Continuation |
|
C Caton |
DA10539-06 |
634,734
|
Service Needs in
Early Psychosis and Drug Use: Continuation |
|
M Devlin |
MH54612-05 |
233,568
|
Psychotherapy and
Medication for Binge Eating Disorder |
|
S Roose |
MH55716-05 |
411,803
|
Antidepressant
Treatment of Melancholia in Late Life |
|
J Mann |
MH56390-05 |
511,159
|
Familial Pathways
to Early-onset Suicide Attempts |
|
J Martin |
NS36835-05 |
300,296
|
Activity Refines
Corticospinal Terminations |
|
M Underwood |
AA11293-04 |
301,937
|
Dorsal Raphe
Nucleus Serotonergic Neurons in Alcoholism |
|
E Nunes |
DA10746-05 |
642,606
|
Opiate Dependence:
Combined Naltrexone/Behavior Therapy |
|
F Levin |
DA11444-05 |
528,706
|
Treatment of Adult
ADHD in Methadone Patients |
|
F Levin |
DA11755-04 |
253,921
|
Methylphenidate
Treatment for Cocaine Abuse and ADHD |
|
J Kline |
AG15386-04 |
242,580
|
Epidemiology of
Trisomy and Ovarian Age |
|
Z Boulos |
NS30528-07 |
101,895
|
Role of Twilights
in Circadian Entrainment |
|
E Susser |
MH58917-04 |
532,433
|
Sexual Risk
Reduction Among Men with Mental Illness |
|
S Comer |
DE12763-04 |
387,889
|
Pain and Analgesic
Response: Sex and Hormone Variations |
|
A Ehrhardt |
MH57636-04 |
1,009,914
|
Health Related
Interventions for Persons Living with HIV |
|
E Rubin |
DA12271-04 |
338,017
|
PET Imaging:
Comorbid Cocaine Dependence and Depression |
|
V Ferrera |
MH59244-04 |
185,873
|
Attention and
Voluntary Action in Prefrontal Cortex |
|
J Prudic |
MH59069-04 |
554,051
|
ECT Practices in
Community Settings: Evaluating Outcomes |
|
A Whitaker |
MH57514-04 |
662,244
|
Epidemiology of
Early CNS Injury & Psychopathology at 13 |
|
S Comer |
DA10909-04 |
363,410
|
Buprenorphine Abuse
by Humans: Laboratory Studies |
|
J Gorman |
MH58808-03 |
268,518
|
The Role of
Transthyretin in Depression |
|
A Dwork |
MH60877-07 |
351,106
|
AD-Like Pathology
in Elderly Schizophrenia |
|
D Shaffer |
MH60570-03 |
1,294,404
|
Child Psychiatry
Intervention Research Center |
|
A Abi-Dargham |
MH59144-03 |
281,583
|
Prefrontal D1 and
5HT1A Receptors in Schizophrenia |
|
F Levin |
DA12761-03 |
1,108,152
|
Novel
Pharmacotherapies for Cocaine Dependence |
|
J Gorman |
MH59342-03 |
760,794
|
MHCRC in
Schizophrenia Studies |
|
W Clark |
DE12725-03 |
296,911
|
Gender Differences
in Pain Sensation and Pain Report |
|
T Exner |
HD37343-03 |
678,248
|
Increasing Dual
Protection Among Low Income Minority Women |
|
H Kleber |
DA12644-03 |
798,459
|
A Study of
Anesthesia-Assisted Herion Detoxification |
|
B Beebe |
MH56130-03 |
64,388
|
Mother-Infant
Regulation: Depression and Attachment |
|
M Weissman |
MH60912-03 |
346,312
|
Genetics of
Early-Onset Major Depression |
|
E Nunes |
DA13118-03 |
227,402
|
Behavioral Therapy
for Depression in Drug Dependence |
|
R Remien |
MH61173-03 |
723,308
|
Serodiscordant
Couples, Medical Adherence and HIV Risk |
|
S Evans |
AA12599-03 |
538,829
|
Medications
Development for Alcohol Abuse: NMDA Agents |
|
D Malaspina |
MH59114-03 |
779,794
|
Jerusalem Perinatal
Cohort Schizophrenia Study |
|
W Fifer |
MH58769-04 |
25,750
|
Meeting of the
International Society for Developmental Psychobiology
|
|
S Lisanby |
MH60884-03 |
297,582
|
Magnetic
Stimulation Therapy: A New Convulsive Treatment |
|
F Schneier |
MH59850-03 |
285,979
|
Imaging of the
Dopamine System in Social Phobia |
|
N Qian |
MH54125-07 |
202,596
|
Computation and
Psychophysics of Motion and Stereopsis |
|
S Donovan |
DA12234-03 |
367,837
|
Temper, Mood
Swings & Marijuana - A Treatable Syndrome? |
|
J Gorman |
MH60951-03 |
436,016
|
Prospective Study
of Relapse Predictors in Panic Disorder |
|
H M-Bahlburg |
HD38409-03 |
138,248
|
Psychobiology of
Cogential Adrenal Hyperplasia (CAH) |
|
R Neugebauer |
MH59179-02 |
69,042
|
Preventing
Depression After Miscarriage: A Pilot Study |
|
J Knowles |
DA12190-02 |
441,691
|
Genetic Risk
Factors for Nicotine Addiction |
|
J Gorman |
MH61274-02 |
497,289
|
CoGent for Mood and
Anxiety Disorder Research |
|
B Walsh |
MH60271-02 |
392,850
|
Fluoxetine After
Weight Restoration in Anorexia Nervosa |
|
B Stanley |
MH61017-02 |
901,621
|
Treating Suicidal
Behavior and Self-Mutilation in BPD |
|
J Mann |
MH62185-02 |
2,155,643
|
Conte Centers for
the Neuroscience of Mental Disorders (CCNMD): The Neurobiology of
Suicidal Behavior |
|
L Greenhill |
MH060903-02 |
550,944
|
Methylphenidate
Efficacy and Safety in ADHD Preschoolers |
|
R Waterhouse |
NS40402-02 |
207,106
|
Development of a
PET Radiotracer for Sigma-1 Receptors |
|
D Mcdowell |
DA13191-02 |
368,238
|
Marijuana
Pharmacotherapies: Controlled Clinical Trials |
|
L Covey |
DA13490-02 |
526,473
|
Maintenance
Treatment for Prevention of Smoking Relapse |
|
M Haney |
DA12698-02 |
455,784
|
THC and Marijuana:
Effects in Individuals with HIV/AIDS |
|
J Rabkin |
MH60563-02 |
410,165
|
DHEA Effects on
Mood in Depressed HIV+ Patients |
|
S Evans |
DA12675-02 |
266,415
|
Cocaine's Effects
Across the Menstrual Cycle |
|
M Oquendo |
MH59710-02 |
683,490
|
Pharmacotherapy of
High-Risk Bipolar Disorder |
|
E Petkova |
MH61968-02 |
78,232
|
Adolescent Eating
Disorders: A Second Look |
|
A Abi-Dargham |
AA12759-02 |
340,468
|
Imaging
Ventrostriatal Dopamine Transmission in Alcoholism
|
|
P Cohen |
MH60911-02 |
612,417
|
Personality
Disorder Over 20 Years: Risks, Course & Impact |
|
H Andrews |
AG16381-02 |
213,251
|
Multicenter Vitamin
E Trial in Persons with Down Syndrome |
|
E Nunes |
DA13035-02 |
1,800,000
|
CU Partners:
NY/Long Island Regional Node |
|
S Schacher |
MH60387-02 |
197,229
|
Mechanisms
Mediating Long-Term Synaptic Plasticity |
|
H Sackeim |
MH61609-02 |
214,143
|
Optimization of
Electroconvulsive Therapy |
|
D Herman |
MH59716-01A2 |
517,898
|
CTI in the
Transition from Hospital to Community |
|
C Mellins |
MH63636-01 |
452,808
|
Risk and Resilience
in Youth with HIV+ Mothers |
|
G Barr |
DA13794-01A1 |
195,460
|
Chronic Opiates
During Ontogeny: A Microarray Analysis |
|
B Peterson |
MH59139-03 |
470,560
|
FMRI Studies of
Impulse Control in Childhood Disorders |
|
P Cohen |
HD40685-01A1 |
477,673
|
Change in Women's
Roles & Well-Being: Age-Cohort Effects |
|
A Dwork |
MH64168-01 |
285,351
|
Golgi Studies of
Schizophrenia |
|
E Smailes |
OH07370-01 |
39,832
|
Difficult Work
Conditions and Youths' Mental Health |
|
M Myers |
ES11596-01 |
367,228
|
Fetal Origins of
Disease: Markers, Modulators, Mechanisms |
|
M Feldman |
DA14592-01 |
79,500
|
Adolescent
Substance Use, Suicide and Sexual Orientation |
|
L O'sullivan |
HD41721-01 |
334,113
|
Assessment of
Gender to Identify Heterosexuals at Risk |
|
W Van Gorp |
MH60560-04 |
417,497
|
Return to Work with
HIV/AIDS: Neuropsychiatric Factors |
|
P Mcgrath |
AA13303-01 |
570,094
|
Alcohol Use
Disorder in Patients Treated for Depression |
|
M Gould |
MH64632-01 |
623,024
|
Evaluating
Iatrogenic Risk of Suicide Screening Programs |
|
C Schmauss |
MH56123-06A1 |
272,216
|
D3 Pre-mRNA
Processing in Chronic Psychosis |
|
R Klitzman |
HG02431-01 |
439,404
|
Views of Privacy of
Genetic Information |
|
B Stanley |
MH62665-01A1 |
303,062
|
Prospective Study
of Suicidal Behavior in BPD |
|
B Walsh |
MH65024-01 |
578,613
|
Translational
Research on Eating Disorders |
|
M Myers |
COLUMBIA UNIVERSITY |
69,489
|
Subcontract w/CU:
Fetal Activity and Hypoxia During Development |
|
H Andrews |
COLUMBIA UNIVERSITY |
48,390
|
Subcontract w/CU:
Epidemiology of Dementia in an Urban Community |
|
M Baron |
COLUMBIA UNIVERSITY |
199,544
|
Subcontract w/CU:
Molecular Genetics of Bipolar Disorder |
|
L Miller |
WT GRANT |
60,000
|
Religiosity and
Resilience in Adolescents |
|
J Javitch |
MOUNT SINAI |
100,697
|
Subcontract w/Mt.
Sinai: Structure and Function of Neurotransmitter Transporters
|
|
J Schwartz |
COLUMBIA UNIVERSITY |
69,322
|
Subcontract w/CU:
Protein Kinase C Controls Synaptic Action and Behavior
|
|
C Hoven |
WESTCHESTER COMM. |
297,335
|
Subcontract w/Dept.
of Community Mental Health: The Westchester Community Network |
|
J Gorman |
CORNELL UNIVERSITY |
145,367
|
Consortium
w/Cornell Univ.: Center for Neural Systems of Fear and Anxiety
|
|
B Fallon |
COLUMBIA UNIVERSITY |
125,958
|
Subcontract w/CU:
PET and MRI Imaging of Persistent Lyme Encephalopathy
|
|
R Hen |
MOUNT SINAI |
172,325
|
Subcontract w/Mt.
Sinai: Hallucinogens and 5-HTZA Receptors |
|
M Myers |
COLUMBIA UNIVERSITY |
19,884
|
Subcontract w/CU:
Hostility Reduction and Autonmic Control of the Heart
|
|
C Hoven |
COLUMBIA UNIVERSITY |
10,031
|
Subcontract w/CU:
Trauma: Focused Intervention Targeting Risk Factors for Violence |
|
C Hoven |
CAMBRIDGE HEALTH |
17,056
|
Consortium
w/Cambridge Health Alliance: Children's Health Initiative II
|
|
G Mathew |
NARSAD |
30,000
|
Neuroimaging
Studies in Adversely Reared Nonhuman Primates |
|
A Fyer |
NARSAD |
99,953
|
An Insolate
Population for Genetic Study of Panic Disorder |
|
H Gordon |
NARSAD |
30,000
|
Neurophysiological
Correlates of Hippocampal Serotonin-1A Receptor Function
|
|
L Guo |
NARSAD |
30,000
|
The Impact of Group
Two Metabtropic Glutamate Receptor Agonists on the Increased
Dopamine Release Induced by NMDA |
|
L Blanco |
NARSAD |
30,000
|
Levels of Care in
the Treatment of Depressed Hispanics: Acceptability and Efficacy |
|
X Amador |
NARSAD |
49,928
|
A Double-blind,
Placebo Controlled Study of Medication Adherence and Insight Therapy
(MAIT) for Schizophrenia |
|
G Printz |
NARSAD |
30,000
|
Central Thyroid
Function and Response to Thyroxine Augmentation in Bipolar
Depression |
|
W Smith |
NARSAD |
30,000
|
Pilot Study of
Fluoxetine in Severely Depressed Adolescents |
|
B Peterson |
TOURETTE SYNDROME |
75,000
|
Neuroimaging
Studies of the Amygdala and Hippocampus in Tourette Syndrome
|
|
F Levin |
NARSAD |
49,992
|
Treatment of
Cocaine and/or Marijuana Abuse Among Patients with Schizophrenia
|
|
R Berman |
NARSAD |
30,000
|
Steroid Regulation
of Brain Hedonic Pathways |
|
D Velting |
CIS |
20,000
|
Mindfulness Skills
Training for Depressed and Suicidal Adolescents |
|
M Gould |
AFSP |
49,661
|
The Role of the
Media in Initiating Teenage Suicide Clusters |
|
D Velting |
KLINGENSTEIN FND |
30,000
|
A Survival Skills
Program: Dialectical Behavior Therapy for Depressed Youth
|
|
D Malaspina |
DREYFUS HEALTH FND |
25,000
|
Neuroprotection in
Stress-Related Schizophrenia (GR-1100-01) |
|
J Knowles |
YESHIVA UNIV |
216,459
|
Subcontract
w/Yeshiva Univ: Genome-wide Analysis for Addiction Susceptibility
Genes |
|
P Jensen |
W. KELLOGG FDND |
65,000
|
Child Mental Health
Foundations and Agencies Network (FAN) Consultant Grant
|
|
H Tamir |
AFSP |
50,000
|
5-HT1A
Receptor-Mediated Activation of G Proteins in Brains of Suicide
Victims |
|
P Jensen |
MAC ARTHUR FND |
12,000
|
Child Mental Health
Foundations and Agencies Network (FAN) Consultation Grant
|
|
J Stewart |
NARSAD |
49,680
|
A Pilot Study of
Refractory Depression Investigating Different Treatments for
Specific Subtypes
|
|
P Jensen |
FOUND CHILD DEV |
5,000
|
Child Mental Health
Foundations and Agencies Network (FAN) Consultation Grant
|
|
D Malaspina |
NARSAD |
49,955
|
New Mutations and
Neurodevelopmental Schizophrenia |
|
J Knowles |
NARSAD |
30,000
|
Anxiety Disorder
Genetics in a Homogenous Population |
|
J Knowles |
JOHNS HOPKINS UNIVERSITY |
156,513
|
Subcontract with
John Hopkins University: Collaborative OCD Genetics Study
|
|
P Jensen |
ANNIE CASEY FDND |
25,000
|
Child Mental Health
Foundations and Agencies Network (FAN) Consultation Grant
|
|
P Jensen |
COMMONWEALTH FUND |
30,000
|
Child Mental Health
Foundations and Agencies Network (FAN) Consultant Grant
|
|
Z Boulos |
UNIV OF HOUSTON |
29,197
|
Subcontract with
Univ of Houston: Neurochemical Regulation of Circadian Timing
|
|
P Jensen |
PACKARD FOUNDATION |
36,000
|
Child Mental Health
Foundations and Agencies Network (FAN) Consultation Grant
|
|
P Jensen |
E M KAUFFMAN FND |
75,000
|
Child Mental Health
Foundations and Agencies Network (FAN) Consultation Grant
|
|
P Jensen |
COORDINATED CARE |
180,120
|
School Based Mental
Health Project Scope of Services |
|
L Greenhill |
YALE UNIVERSITY |
26,818
|
Statistical Support
Services for RUPP Autism Studies |
|
A Carballo |
COLUMBIA UNIVERSITY |
74,955
|
Subcontract w/CU:
The NYC Collaborative to Address HIV Risks among Latino MSM |
|
P Jensen |
ANNIE E. CASEY |
52,500
|
Child Mental Health
Foundations and Agencies Network (FAN) Consultation
|
|
B Waslick |
DUKE UNIVERSITY |
268,707
|
Treatment of
Adolescent Depression Study |
|
L Covey |
COVANCE |
15,610
|
Beflaxotone for
Smoking Cessation Study |
|
M Liebowitz |
WYETH-AYERST |
104,160
|
A Double-Blind,
Placebo-Controlled Study of a Flexible Dose of Venlafaxine ER in
Adult Outpatients with Generalized Social Anxiety Disorder
|
|
B Walsh |
KNOLL PHARMACEUTICAL |
79,775
|
Efficacy and Safety
of Meridia in Binge Eating Disorder |
|
A Glassman |
PFIZER |
35,878
|
A 7-Week
Double-Blind, Placebo-Controlled, Randomized, Multicenter Study
Evaluating the Safety & Efficacy of 3 Doses of CP-526,555 in
Comparison with Zyban SR in Smoking Cessation |
|
L Greenhill |
CEPHALON |
38,770
|
Modafinil Analog
Classroom ADHD Study |
|
H Sackeim |
CYBERONICS |
82,031
|
Cyberonics - HRSD
Training |
|
M Liebowitz |
WARNER-LAMBERT |
22,187
|
An 8-Week
Double-Blind, Randomized, Multicenter Flexible Dose Range Placebo
Controlled Study of Pagoclone in Patients with Panic Disorder
|
|
P Mcgrath |
QUINTILES |
63,647
|
Safety and Efficacy
of Naltrel in Treatment of Alcohol Dependence |
|
L Greenhill |
NOVEN PHARMACEUTICAL |
17,450
|
A Multicenter,
Double-Blind, Placebo-Controlled Safety & Efficacy Study of MTS in
Pediatric Patients with ADHD |
|
Z Sharif |
BRISTOL MYERS |
111,350
|
Aripiprazole vs.
Perphenazine in Treatment Resistant Schizophrenia
|
|
D Devanand |
WYETH-AYERST |
22,500
|
Open Venlafaxine
Treatment of Dysthymic Disorder in the Elderly |
|
J Coplan |
SMITHKLINE BEECH |
64,188
|
Neuroimaging
Studies in Generalized Anxiety Disorder During Treatment with
Paroxetine |
|
S Seidman |
PFIZER |
91,916
|
Evaluation od
Safety and Efficacy of Viagra |
|
F Schneier |
FOREST LABORATORY |
82,288
|
Citalopram
Treatment of Social Phobia with Comorbid Depression
|
|
J Coplan |
FOREST LABORATORY |
14,063
|
Citalopram
Treatment for Irritable Bowel Syndrome (IBS) Comorbid with Anxiety
Disorders |
|
M Spinelli |
PHERIN PHARM |
19,250
|
A Phase 2 Study of
the Use of PH80 for Management of the Symptoms of Clinically
Significant Premenstrual Syndrome (PMS) |
|
J Endicott |
MERCK RES LAB |
8,480
|
Acute & Extension
Study of MK-0869 in Treatment of Patients w/Major Depressive
Disorder |
|
D Printz |
PFIZER |
105,741
|
A Prospective
Open-Label Study of Ziprasidone in the Treatment of Bipolar I
Depression |
|
L Greenhill |
NOVEN PHARMACEUTICAL |
23,578
|
Noven
Methylphenidate Transdermal System Acute and Long Term Trials
|
|
S Roose |
MERCK RES LAB |
21,946
|
Multicenter Study
of the Long Term Efficacy of MK-0869 in the Maintenance of
Antidepressant Effect in Geriatric Outpatients. |
|
M Laruelle |
LILLY RESEARCH |
24,434
|
Assessing the In
Vivo D2 Receptor Occupancy of IM Olanzapine Depot (Pamoate) Using
PET in Patients w/ Schizophrenia |
|
R L-Fernandez |
PFIZER |
50,000
|
Training and
Consultation-Liaison Program Between Academic Psychiatrists and
Community Based PMD's |
|
J Endicott |
PFIZER |
20,000
|
Psychometric
Assessment of the Reliability and Validity of Two Outcome Measures
For Use In A Chronic Spinal Cord Injury Population |
|
C Blanco |
OY CONTRAL PHARMA |
16,455
|
Nalmefene in the
Treatment of Pathological Gambling. A Placebo-Controlled
Dose-Response Study |
|
B Waslick |
JOHNSON & JOHNSON |
7,490
|
The Efficacy and
Safety of Risperidone in the Treatment of Children and Adolescents
with Schizophrenia |
|
G Pelton |
JEWISH COMMUNAL |
15,000
|
Effects of
Peripheral Immune Stimulation on Brain Activity |
|
D Klein |
ELI LILLY |
50,000
|
General Support
|
|
R Marshall |
N Y TIMES FND |
2,225,000
|
The NYC Consortium
for Effective Trauma Treatment |
|
R L-Fernandez |
N Y TIMES FND |
50,000
|
Improving Mental
Health Services in Primary Care Settings of Hispanic Outpatients
Affected by the World Trade Ctr Disaster |
|
R Neugebauer |
VARIOUS DONORS |
7,827 |
Preventing
Depression after Miscarriage: A Pilot Study |
|
R Marshall |
SURDNA FOUNDATION |
235,000
|
The NYC Consortium
for Effective Trauma Treatment |
|
P Mcgrath |
MCCARRON |
4,814
|
Research on
Depression in an Adult Population |
|
E Struening |
NYC #02206 |
25,375
|
CSS-Case Management
Study: A Plus West 168th Street |
|
E Struening |
NYC #02206 |
548,750
|
CSS-Shelter and
Survey 93 Worth Street |
|
E Struening |
NYC #02206 |
220,644
|
CSS-Shelter and
Survey-93 Worth Street |
|
B Link |
OMH |
275,000
|
The Evaluation of
Assisted Outpatient Treatment |
|
Sponsored Research Total |
56,505,676 |
|
